BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA
* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA
TORONTO, April 19 Canada's main stock index gained in early trade on Wednesday, helped by a rebound in banking stocks after recent losses and a jump in shares of Rogers Communications Inc after it reported strong quarterly earnings.
The Toronto Stock Exchange's S&P/TSX composite index was up 58.85 points, or 0.38 percent, at 15,681.42 shortly after the open. Eight of its 10 main groups gained. (Reporting by Alastair Sharp)
* Korea stocks, won down after Trump says trade deal needs change